# Best of Lung Cancer Science - European Society for Medical Oncology (ESMO)

Page: https://stenobird.com/podcast/thinking-thoracic-7116337/best-of-lung-cancer-science-european-society-for-medical-oncology-esmo
Text version: https://stenobird.com/podcast/thinking-thoracic-7116337/best-of-lung-cancer-science-european-society-for-medical-oncology-esmo.md
Podcast: [Thinking Thoracic](https://stenobird.com/podcast/thinking-thoracic-7116337)
Published: 2026-02-18T21:32:31+00:00
Episode link: https://thinkingthoracic.podbean.com/e/best-of-lung-cancer-science-european-society-for-medical-oncology-esmo/
Audio file: https://mcdn.podbean.com/mf/web/76yri2fcu6gxnrf3/25-12_-_EP4_-_Jessica_Christine_Audio_Only_1_7h3ib.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/thinking-thoracic-7116337/episodes/best-of-lung-cancer-science-european-society-for-medical-oncology-esmo
Duration seconds: 4272

## Resource

Jessica Donington, MD, and Christine Bestvina, MD, join Dr. Gillaspie to unpack key lung cancer advances from ESMO, including adjuvant ALK inhibition (ALINA, ELEVATE), perioperative immunotherapy (KEYNOTE-671), and the expanding neoadjuvant space in borderline resectable disease.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/thinking-thoracic-7116337/episodes/best-of-lung-cancer-science-european-society-for-medical-oncology-esmo/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/thinking-thoracic-7116337/best-of-lung-cancer-science-european-society-for-medical-oncology-esmo.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.